BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9607645)

  • 21. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ; Kelder JC
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome.
    Haga HJ; Rygh T
    J Rheumatol; 1999 Jun; 26(6):1291-5. PubMed ID: 10381045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sjögren's Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin.
    Anaya JM; Restrepo-Jiménez P; Rodríguez Y; Rodríguez-Jiménez M; Acosta-Ampudia Y; Monsalve DM; Pacheco Y; Ramírez-Santana C; Molano-González N; Mantilla RD
    Clin Rev Allergy Immunol; 2019 Jun; 56(3):362-374. PubMed ID: 30187363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren's syndrome and mixed connective tissue disease.
    Ohtsuka E; Nonaka S; Shingu M; Yasuda M; Nobunaga M
    Clin Exp Rheumatol; 1992; 10(4):339-44. PubMed ID: 1395218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary Sjögren's syndrome: clinical and immunological characteristics of 114 patients].
    Selva O'Callaghan A; Bosch Gil JA; Solans Laque R; Segura García A; Armadans Gil L; Mijares Boeckh-Behrens T; Vilardell Tarrés M
    Med Clin (Barc); 2001 May; 116(19):721-5. PubMed ID: 11412691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Sjögren's syndrome in rheumatoid arthritis.
    He J; Ding Y; Feng M; Guo J; Sun X; Zhao J; Yu D; Li Z
    Rheumatology (Oxford); 2013 Jun; 52(6):1084-9. PubMed ID: 23382356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
    J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome.
    Kirtava Z; Blomberg J; Bredberg A; Henriksson G; Jacobsson L; Manthorpe R
    Clin Exp Rheumatol; 1995; 13(5):609-16. PubMed ID: 8575139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.
    Tobón GJ; Saraux A; Gottenberg JE; Quartuccio L; Fabris M; Seror R; Devauchelle-Pensec V; Morel J; Rist S; Mariette X; De Vita S; Youinou P; Pers JO
    Arthritis Rheum; 2013 Dec; 65(12):3218-27. PubMed ID: 23982978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.
    Kvarnström M; Ottosson V; Nordmark B; Wahren-Herlenius M
    Scand J Rheumatol; 2015; 44(2):135-42. PubMed ID: 25222653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.